Pelthos Therapeutics Inc.

New Filing
CIK: 0001919246·Pharmaceuticals·NEVADA·Filed: Nov 16, 2026
Total Offering

$57,500,000

Amount Sold

$57,500,000

Investors

7

First Sale

Oct 30, 2026

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Scott Plesha
Related Person
John M. Gay
Related Person
Sai Rangarao
Related Person
Richard Baxter
Related Person
Peter Greenleaf
Related Person
Ezra Friedberg
Related Person
Todd Davis
Related Person
Richard Malamut
Related Person
Matthew Pauls
Related Person
Andrew Einhorn
Related Person

Company

Pelthos Therapeutics Inc.

4020 Stirrup Creek Drive, Suite 110

Durham, NC, 27703

919-908-2400

SEC Filing

0001919246-26-000142

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free